{"transactions":[{"id":677328,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T20:58:19.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":262751,"source":{"system":"sec-edgar","filing":"0001628280-26-058673","document":"wk-form4_1787605097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058673/wk-form4_1787605097.xml","form_type":"4"}},{"id":677325,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:14:15.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1737,"price":7.71,"value":13392.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":183551,"source":{"system":"sec-edgar","filing":"0001628280-26-058588","document":"wk-form4_1787598852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058588/wk-form4_1787598852.xml","form_type":"4"}},{"id":774865,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:43:36.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5219,"price":5.21,"value":27190.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":185288,"source":{"system":"sec-edgar","filing":"0001628280-26-035998","document":"wk-form4_1779137014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026035998/wk-form4_1779137014.xml","form_type":"4"}},{"id":959538,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-23T22:43:26.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3361,"price":12.74,"value":42819.14,"ownership":{"direct":true},"balance_after":190507,"source":{"system":"sec-edgar","filing":"0001628280-25-058799","document":"wk-form4a_1766529803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058799/wk-form4a_1766529803.xml","form_type":"4/A","original_submission_date":"2025-12-23"}},{"id":959536,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:54:50.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3361,"price":12.74,"value":42819.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":190507,"source":{"system":"sec-edgar","filing":"0001628280-25-058768","document":"wk-form4_1766526886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058768/wk-form4_1766526886.xml","form_type":"4"}},{"id":960848,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":6547,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":960847,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1594,"price":13.51,"value":21534.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":193868,"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":960846,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":195462,"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":1022135,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1022134,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":1620,"price":18.75,"value":30375.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":188916,"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1022133,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":190536,"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1056756,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-08-25T20:32:47.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041119","document":"wk-form4_1756153962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041119/wk-form4_1756153962.xml","form_type":"4"}},{"id":1056755,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-25T20:32:47.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":183887,"source":{"system":"sec-edgar","filing":"0001628280-25-041119","document":"wk-form4_1756153962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041119/wk-form4_1756153962.xml","form_type":"4"}},{"id":1142541,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2025-05-19T20:03:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":80884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date."}],"balance_after":80884,"derivative":{"exercise_price":10.65,"exercise_date":"2026-05-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":80884},"source":{"system":"sec-edgar","filing":"0001628280-25-026499","document":"wk-form4_1747685005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026499/wk-form4_1747685005.xml","form_type":"4"}},{"id":1142540,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:03:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":46948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant."}],"balance_after":168262,"source":{"system":"sec-edgar","filing":"0001628280-25-026499","document":"wk-form4_1747685005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026499/wk-form4_1747685005.xml","form_type":"4"}},{"id":1227925,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":1928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1928},"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1227924,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":572,"price":5.18,"value":2962.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":121314,"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1227923,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":121886,"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1255619,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-20T18:39:20.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2298,"price":6.64,"value":15258.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":119958,"source":{"system":"sec-edgar","filing":"0001628280-25-006689","document":"wk-form4_1740076754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025006689/wk-form4_1740076754.xml","form_type":"4"}},{"id":1320938,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2024-12-27T20:18:54.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":77742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date."}],"balance_after":77742,"derivative":{"exercise_price":4.83,"exercise_date":"2025-12-23","expiration_date":"2027-12-23","underlying":"Common Stock","underlying_shares":77742},"source":{"system":"sec-edgar","filing":"0001628280-24-052490","document":"wk-form4_1735330727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024052490/wk-form4_1735330727.xml","form_type":"4"}},{"id":1320937,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-27T20:18:54.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":41408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant."}],"balance_after":122256,"source":{"system":"sec-edgar","filing":"0001628280-24-052490","document":"wk-form4_1735330727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024052490/wk-form4_1735330727.xml","form_type":"4"}},{"id":1324006,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T00:47:42.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":13093,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001628280-24-052286","document":"wk-form4_1734742056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024052286/wk-form4_1734742056.xml","form_type":"4"}},{"id":1324005,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-21T00:47:42.000Z","date":"2024-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2576,"price":4.75,"value":12236.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":80848,"source":{"system":"sec-edgar","filing":"0001628280-24-052286","document":"wk-form4_1734742056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024052286/wk-form4_1734742056.xml","form_type":"4"}},{"id":1324004,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-21T00:47:42.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":83424,"source":{"system":"sec-edgar","filing":"0001628280-24-052286","document":"wk-form4_1734742056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024052286/wk-form4_1734742056.xml","form_type":"4"}},{"id":1390060,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-08T01:24:44.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":6649,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-24-042475","document":"wk-form4_1728350678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024042475/wk-form4_1728350678.xml","form_type":"4"}},{"id":1390059,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-08T01:24:44.000Z","date":"2024-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2617,"price":7.83,"value":20491.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":76878,"source":{"system":"sec-edgar","filing":"0001628280-24-042475","document":"wk-form4_1728350678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024042475/wk-form4_1728350678.xml","form_type":"4"}},{"id":1390058,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-08T01:24:44.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":79495,"source":{"system":"sec-edgar","filing":"0001628280-24-042475","document":"wk-form4_1728350678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024042475/wk-form4_1728350678.xml","form_type":"4"}},{"id":1526247,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-07T01:35:52.000Z","date":"2024-05-02","kind":"exercise","planned":false,"acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units cliff vested in full on May 2, 2024, the fifth anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units cliff vested in full on May 2, 2024, the fifth anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-02","expiration_date":"2024-05-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001628280-24-020821","document":"wk-form4_1715045740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020821/wk-form4_1715045740.xml","form_type":"4"}},{"id":1526246,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T01:35:52.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":35415,"price":10.7,"value":378940.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":72846,"source":{"system":"sec-edgar","filing":"0001628280-24-020821","document":"wk-form4_1715045740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020821/wk-form4_1715045740.xml","form_type":"4"}},{"id":1526245,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T01:35:52.000Z","date":"2024-05-02","kind":"exercise","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":108261,"source":{"system":"sec-edgar","filing":"0001628280-24-020821","document":"wk-form4_1715045740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020821/wk-form4_1715045740.xml","form_type":"4"}},{"id":1526244,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T01:34:27.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":572,"price":15.95,"value":9123.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. The  original Form 4 filed by the Reporting Person reporting this transaction overstated the number of shares withheld by the Issuer."}],"balance_after":18261,"source":{"system":"sec-edgar","filing":"0001628280-24-020819","document":"wk-form4a_1715045619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020819/wk-form4a_1715045619.xml","form_type":"4/A","original_submission_date":"2024-03-06"}},{"id":1526243,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T01:34:27.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement."}],"balance_after":18833,"source":{"system":"sec-edgar","filing":"0001628280-24-020819","document":"wk-form4a_1715045619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020819/wk-form4a_1715045619.xml","form_type":"4/A","original_submission_date":"2024-03-06"}},{"id":1526242,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-07T01:32:20.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":7750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 as originally filed reported in Table 1 a grant of Common Stock on March 15, 2024.  However, this transaction occurred on February 15, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement."}],"balance_after":16906,"source":{"system":"sec-edgar","filing":"0001628280-24-020817","document":"wk-form4a_1715045531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024020817/wk-form4a_1715045531.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1536108,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-04-24T14:04:19.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":7750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant."}],"balance_after":13706,"source":{"system":"sec-edgar","filing":"0001628280-24-017545","document":"wk-form4_1713967450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024017545/wk-form4_1713967450.xml","form_type":"4"}},{"id":1591504,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T21:20:28.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":1928,"derivative":{"underlying":"Common Stock","underlying_shares":1927},"source":{"system":"sec-edgar","filing":"0001628280-24-009407","document":"wk-form4_1709760003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024009407/wk-form4_1709760003.xml","form_type":"4"}},{"id":1591503,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T21:20:28.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":668,"price":15.95,"value":10654.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":5956,"source":{"system":"sec-edgar","filing":"0001628280-24-009407","document":"wk-form4_1709760003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024009407/wk-form4_1709760003.xml","form_type":"4"}},{"id":1591502,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T21:20:28.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":6624,"source":{"system":"sec-edgar","filing":"0001628280-24-009407","document":"wk-form4_1709760003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024009407/wk-form4_1709760003.xml","form_type":"4"}},{"id":1628959,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T23:22:31.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":19639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":19639,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":19639},"source":{"system":"sec-edgar","filing":"0001628280-24-006018","document":"wk-form4_1708557741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024006018/wk-form4_1708557741.xml","form_type":"4"}},{"id":1628958,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2024-02-21T23:22:31.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":19639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":19639,"derivative":{"exercise_price":12.73,"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":19639},"source":{"system":"sec-edgar","filing":"0001628280-24-006018","document":"wk-form4_1708557741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024006018/wk-form4_1708557741.xml","form_type":"4"}},{"id":1763441,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:47:39.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":13298,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-23-034060","document":"wk-form4_1696618044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023034060/wk-form4_1696618044.xml","form_type":"4"}},{"id":1763440,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-10-06T18:47:39.000Z","date":"2023-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":7.06,"value":13781.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":4697,"source":{"system":"sec-edgar","filing":"0001628280-23-034060","document":"wk-form4_1696618044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023034060/wk-form4_1696618044.xml","form_type":"4"}},{"id":1763439,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-10-06T18:47:39.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":6649,"source":{"system":"sec-edgar","filing":"0001628280-23-034060","document":"wk-form4_1696618044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023034060/wk-form4_1696618044.xml","form_type":"4"}},{"id":1972930,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T20:40:35.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":3855,"derivative":{"underlying":"Common Stock","underlying_shares":1927},"source":{"system":"sec-edgar","filing":"0001628280-23-006261","document":"wf-form4_167787601944224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006261/wf-form4_167787601944224.xml","form_type":"4"}},{"id":1972929,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T20:40:35.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":668,"price":18.11,"value":12097.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":4459,"source":{"system":"sec-edgar","filing":"0001628280-23-006261","document":"wf-form4_167787601944224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006261/wf-form4_167787601944224.xml","form_type":"4"}},{"id":1972928,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T20:40:35.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":5127,"source":{"system":"sec-edgar","filing":"0001628280-23-006261","document":"wf-form4_167787601944224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006261/wf-form4_167787601944224.xml","form_type":"4"}},{"id":2142149,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-10-05T17:18:37.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":39055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":39055,"derivative":{"exercise_price":15.04,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":39055},"source":{"system":"sec-edgar","filing":"0001628280-22-026033","document":"wf-form4_166499030249017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022026033/wf-form4_166499030249017.xml","form_type":"4"}},{"id":2142148,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T17:18:37.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":19947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":19947,"derivative":{"underlying":"Common Stock","underlying_shares":19947},"source":{"system":"sec-edgar","filing":"0001628280-22-026033","document":"wf-form4_166499030249017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022026033/wf-form4_166499030249017.xml","form_type":"4"}},{"id":2181504,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2022-08-17T20:46:17.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":3200,"price":15.66,"value":50112.0,"ownership":{"direct":true},"balance_after":3200,"source":{"system":"sec-edgar","filing":"0001213900-22-049032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022049032/ownership.xml","form_type":"4"}},{"id":2353951,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:46:02.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":5782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":5782,"derivative":{"underlying":"Common Stock","underlying_shares":5782},"source":{"system":"sec-edgar","filing":"0001213900-22-010599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010599/ownership.xml","form_type":"4"}},{"id":2353950,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-03-03T21:46:02.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":11726,"derivative":{"exercise_price":43.24,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":11726},"source":{"system":"sec-edgar","filing":"0001213900-22-010599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010599/ownership.xml","form_type":"4"}},{"id":2462374,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-12-21T21:45:37.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":13241,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38511,"derivative":{"exercise_price":7.51,"exercise_date":"2020-12-30","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13241},"source":{"system":"sec-edgar","filing":"0001213900-21-066731","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021066731/ownership.xml","form_type":"4"}},{"id":2462373,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-12-21T21:45:37.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":13241,"price":54.87,"value":726533.67,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-066731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021066731/ownership.xml","form_type":"4"}},{"id":2462372,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-12-21T21:45:37.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":13241,"price":7.51,"value":99439.91,"ownership":{"direct":true},"balance_after":13241,"source":{"system":"sec-edgar","filing":"0001213900-21-066731","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021066731/ownership.xml","form_type":"4"}},{"id":2502694,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-11-19T21:45:09.000Z","date":"2021-11-17","kind":"exercise","acquired":false,"shares":13241,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51752,"derivative":{"exercise_price":7.51,"exercise_date":"2020-12-30","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13241},"source":{"system":"sec-edgar","filing":"0001213900-21-060876","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021060876/ownership.xml","form_type":"4"}},{"id":2502693,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-11-19T21:45:09.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":13241,"price":73.98,"value":979569.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-060876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021060876/ownership.xml","form_type":"4"}},{"id":2502692,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-11-19T21:45:09.000Z","date":"2021-11-17","kind":"exercise","acquired":true,"shares":13241,"price":7.51,"value":99439.91,"ownership":{"direct":true},"balance_after":13241,"source":{"system":"sec-edgar","filing":"0001213900-21-060876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021060876/ownership.xml","form_type":"4"}},{"id":2539193,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-10-19T20:45:21.000Z","date":"2021-10-18","kind":"exercise","acquired":false,"shares":13241,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64993,"derivative":{"exercise_price":7.51,"exercise_date":"2020-09-30","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13241},"source":{"system":"sec-edgar","filing":"0001213900-21-053526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021053526/ownership.xml","form_type":"4"}},{"id":2539192,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-10-19T20:45:21.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":13241,"price":85.38,"value":1130516.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-053526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021053526/ownership.xml","form_type":"4"}},{"id":2539191,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-10-19T20:45:21.000Z","date":"2021-10-18","kind":"exercise","acquired":true,"shares":13241,"price":7.51,"value":99439.91,"ownership":{"direct":true},"balance_after":13241,"source":{"system":"sec-edgar","filing":"0001213900-21-053526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021053526/ownership.xml","form_type":"4"}},{"id":2563036,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Stock Option","published_at":"2021-09-21T20:45:09.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":13242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78234,"derivative":{"exercise_price":7.51,"exercise_date":"2020-03-31","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13242},"source":{"system":"sec-edgar","filing":"0001213900-21-049127","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021049127/ownership.xml","form_type":"4"}},{"id":2563035,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-09-21T20:45:09.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":13242,"price":69.79,"value":924159.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-049127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021049127/ownership.xml","form_type":"4"}},{"id":2563034,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2021-09-21T20:45:09.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":13242,"price":7.51,"value":99447.42,"ownership":{"direct":true},"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001213900-21-049127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021049127/ownership.xml","form_type":"4"}},{"id":2596121,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-08-19T20:45:42.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":13242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91476,"derivative":{"exercise_price":7.51,"exercise_date":"2020-03-31","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13242},"source":{"system":"sec-edgar","filing":"0001213900-21-043903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021043903/ownership.xml","form_type":"4"}},{"id":2596120,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-08-19T20:45:42.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":13242,"price":58.41,"value":773465.22,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-043903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021043903/ownership.xml","form_type":"4"}},{"id":2596119,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-08-19T20:45:42.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":13242,"price":7.51,"value":99447.42,"ownership":{"direct":true},"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001213900-21-043903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021043903/ownership.xml","form_type":"4"}},{"id":2628142,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-07-21T20:45:14.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":13242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":104718,"derivative":{"exercise_price":7.51,"exercise_date":"2020-06-30","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13242},"source":{"system":"sec-edgar","filing":"0001213900-21-037937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021037937/ownership.xml","form_type":"4"}},{"id":2628141,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-07-21T20:45:14.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":13242,"price":50.34,"value":666602.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-037937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021037937/ownership.xml","form_type":"4"}},{"id":2628140,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-07-21T20:45:14.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":13242,"price":7.51,"value":99447.42,"ownership":{"direct":true},"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001213900-21-037937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021037937/ownership.xml","form_type":"4"}},{"id":2660827,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-06-21T20:15:18.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":13242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117960,"derivative":{"exercise_price":7.51,"exercise_date":"2020-03-31","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13242},"source":{"system":"sec-edgar","filing":"0001213900-21-033297","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021033297/ownership.xml","form_type":"4"}},{"id":2660826,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock pursuant to 10B5-1 plan","published_at":"2021-06-21T20:15:18.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":13242,"price":53.44,"value":707652.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-033297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021033297/ownership.xml","form_type":"4"}},{"id":2660825,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-06-21T20:15:18.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":13242,"price":7.51,"value":99447.42,"ownership":{"direct":true},"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001213900-21-033297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021033297/ownership.xml","form_type":"4"}},{"id":2705381,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-05-19T20:45:41.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":13242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":131202,"derivative":{"exercise_price":7.51,"exercise_date":"2020-03-31","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":13242},"source":{"system":"sec-edgar","filing":"0001213900-21-027936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021027936/ownership.xml","form_type":"4"}},{"id":2705380,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-05-19T20:45:41.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":13242,"price":7.51,"value":99447.42,"ownership":{"direct":true},"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001213900-21-027936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021027936/ownership.xml","form_type":"4"}},{"id":2705379,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-05-19T20:45:41.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":13242,"price":42.72,"value":565698.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-027936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021027936/ownership.xml","form_type":"4"}},{"id":2910878,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2021-01-12T00:05:08.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":38511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest 1/3 at the end of each anniversary from issuance."}],"balance_after":144444,"derivative":{"exercise_price":37.5,"exercise_date":"2021-01-07","expiration_date":"2024-01-07","underlying":"Common Stock","underlying_shares":38511},"source":{"system":"sec-edgar","filing":"0001213900-21-001540","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021001540/ownership.xml","form_type":"4"}},{"id":3210948,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2020-03-13T21:21:14.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":105933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest 25% at the end of each quarter starting on 3/31/2020."}],"balance_after":105933,"derivative":{"exercise_price":7.51,"exercise_date":"2020-03-31","expiration_date":"2025-03-11","underlying":"Common Stock","underlying_shares":105933},"source":{"system":"sec-edgar","filing":"0001213900-20-006360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020006360/ownership.xml","form_type":"4"}},{"id":3539766,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Unvested Restricted Stock Grant","published_at":"2019-05-03T21:08:06.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person received 90,000 shares of the Issuer's restricted stock that will vest all at one time upon completion of 5 years of service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received 90,000 shares of the Issuer's restricted stock that will vest all at one time upon completion of 5 years of service."}],"balance_after":90000,"derivative":{"exercise_date":"2024-05-02","expiration_date":"2024-05-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-19-007808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019007808/ownership.xml","form_type":"4"}}]}